HIGHLIGHTS
- who: Leiping Zeng from the Stanford University, Stanford, CA, USA have published the research work: Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS
- what: The authors demonstrate that Cas13d effectively targets and inhibits diverse strains of coronaviruses both as a prophylactic and a treatment, including SARS-CoV-2 and other coronaviruses. The authors provide substantial evidence that CRISPR-Cas13d can work efficiently as a BSA agent against diverse SARS-CoV-2_variants, including Omicron, as well as endemic human respiratory coronavirus strains . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.